Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
Sarah James Reiterated (AMED) at Hold and Held Target at $101 on, Jul 25th, 2024
Sarah James of Cantor Fitzgerald, Reiterated "Amedisys, Inc." (AMED) at Hold and Held Target at $101 on, Jul 25th, 2024.
Sarah has made no other calls on AMED in the last 4 months.
There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 2 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matt Larew of "William Blair" Downgraded from Buy to Hold on, Monday, July 1st, 2024
- John Ransom of "Raymond James" Maintained at Hold on, Tuesday, March 26th, 2024
This is the rating of the analyst that currently disagrees with Sarah
- Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $100 on, Monday, March 25th, 2024
